0001209191-22-014748.txt : 20220302
0001209191-22-014748.hdr.sgml : 20220302
20220302163022
ACCESSION NUMBER: 0001209191-22-014748
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220302
DATE AS OF CHANGE: 20220302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ashburn Theodore
CENTRAL INDEX KEY: 0001627978
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39575
FILM NUMBER: 22704020
MAIL ADDRESS:
STREET 1: 1688 WASHINGTON STREET #1
CITY: BOSTON
STATE: MA
ZIP: 02118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncorus, Inc.
CENTRAL INDEX KEY: 0001671818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473779757
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 HAMPSHIRE STREET
STREET 2: SUITE 401
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-320-6400
MAIL ADDRESS:
STREET 1: 50 HAMPSHIRE STREET
STREET 2: SUITE 401
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-01
0
0001671818
Oncorus, Inc.
ONCR
0001627978
Ashburn Theodore
C/O ONCORUS, INC.
50 HAMPSHIRE STREET, SUITE 401
CAMBRIDGE
MA
02139
1
1
0
0
President and CEO
Employee Stock Option (right to buy)
2.00
2022-03-01
4
A
0
211000
0.00
A
2032-02-29
Common Stock
211000
211000
D
Twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service through each such vesting date.
/s/ Brian J. Shea, Attorney-in-Fact
2022-03-02
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
each of John McCabe and Brian Shea of Oncorus, Inc., and Marc Recht, Courtney T.
Thorne, John Robertson and Jason Minio of Cooley LLP, with full power of
substitution, signing individually, the undersigned's true and lawful
attorneys-in fact and agents to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer, director or beneficial owner of more than 10% of a registered
class of securities of Oncorus, Inc., Forms 3, 4, and 5 (including any
amendments thereto), relating to the securities of Oncorus, Inc., in accordance
with Section 16(a) of the Securities Exchange Act of 1934, as amended (the
"Exchange Act") and the rules thereunder and a Form ID, Uniform Application for
Access Codes to File on EDGAR;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to execute such Forms 3, 4, or 5, or Form ID
(including any amendments thereto) and timely file such forms with the United
States Securities and Exchange Commission and any stock exchange or similar
authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is Oncorus, Inc. assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by Oncorus, Inc., (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact or (c) as to any attorney-in-fact
individually, until such attorney-in-fact is no longer employed by Oncorus, Inc.
or Cooley LLP.
The undersigned has caused this Power of Attorney to be executed as of February
25, 2022.
/s/ Theodore (Ted) Ashburn, M.D., Ph.D.